drugset / Trial / NCT06814106

A Single- and Multiple-Dose Study of Enlicitide Chloride (MK-0616) in Healthy Chinese Adult Participants (MK 0616-010)

NCT06814106

Phase 1 Completed 37 enrolled Merck Sharp & Dohme LLC
RandomizedSequentialDouble-blindBasic science

Summary

The purpose of this study is to learn about the safety of enlicitide chloride and how well people tolerate it. Researchers also want to learn what happens to different amounts of enlicitide chloride in a healthy person's body over time.

Timeline

Start
2023-03-06
Primary completion
2023-05-08
Completion
2023-05-08

Drugs

EvaluationDrugModalityDoseRoute
Subject Enlicitide Unknown Oral

Indications

No indication recorded.